Ben-Gurion University seeking partner to repurpose old lymphoma drug to treat ALS
Researchers at the Ben-Gurion University of the Negev are seeking collaborators who can help them teach an old lymphoma drug a new trick- to treat ALS.
Rachel Lichenstein, a researcher at Ben-Gurion in Israel had been studying the role of sugar molecules in cancer when a student drew her attention to a lab in a nearby hospital that happened to have 20 tissue samples from ALS patients. So Lichenstein figured she might as well check them out.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.